ENOB Enochian Biosciences, Inc.

Enochian BioSciences Inc is an immunotherapy company engaged in developing cures and providing prevention for infectious diseases and cancer. It is also engaged in developing HIV preventative vaccine and cures and Cellular immune-oncology products.

$3.64
As of 03/02/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
02/02/2015
47,763,220
172,624
$173,858,121
0.00%
SEC Edgar Online
10-Q
10-K
29350E104
US29350E1047
BD3NJQ5

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
1.05
0.00
-6.76%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy